Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novozymes AS    NZYM B   DK0060336014

NOVOZYMES AS

(NZYM B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Novozymes : Trading by management and close relations of management

share with twitter share with LinkedIn share with facebook
share via e-mail
01/23/2020 | 01:13pm EST

Read the full announcement in the attached file


Attachment

  • 2020_03_Trading_by_management_EN

© OMX, source OMX

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on NOVOZYMES AS
02/27NOVOZYMES AS : Ex-dividend day for final dividend
FA
02/26NOVOZYMES : New incentive programs for the Executive Leadership Team, the Senior..
AQ
02/26NOVOZYMES A/S : ' annual shareholders' meeting 2020
AQ
02/24NOVOZYMES : Transactions under Novozymes' stock buyback program
PU
02/17NOVOZYMES : Transactions under Novozymes' stock buyback program
AQ
02/12NOVOZYMES : Trading by management and close relations of management
PU
02/10NOVOZYMES : Initiation of stock buyback program
AQ
02/06NOVOZYMES : Trading by management and close relations of management
PU
02/04NOVOZYMES : Trading by management and close relations of management
AQ
01/31NOVOZYMES : Invitation to Novozymes' annual shareholders' meeting 2020
AQ
More news
Financials (DKK)
Sales 2020 14 909 M
EBIT 2020 4 023 M
Net income 2020 3 089 M
Debt 2020 4 018 M
Yield 2020 1,60%
P/E ratio 2020 31,7x
P/E ratio 2021 29,4x
EV / Sales2020 6,88x
EV / Sales2021 6,61x
Capitalization 98 505 M
Chart NOVOZYMES AS
Duration : Period :
Novozymes AS Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVOZYMES AS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 331,06  DKK
Last Close Price 348,90  DKK
Spread / Highest target 21,0%
Spread / Average Target -5,11%
Spread / Lowest Target -21,2%
EPS Revisions
Managers
NameTitle
Ester Baiget President & Chief Executive Officer
Jørgen Buhl Rasmussen Chairman
Thomas Videbaek COO, Executive VP-Research, Innovation & Supply
Lars Green Chief Financial Officer & Executive Vice President
Claus Crone Fuglsang VP-Franklinton Biofuel, Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
NOVOZYMES AS10.00%14 804
ECOLAB INC.0.75%56 043
HENKEL AG & CO. KGAA-4.36%39 260
GIVAUDAN5.21%30 384
SIKA AG-0.91%26 981
EMS-CHEMIE HOLDING AG-5.18%14 466